A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors-Reference-Cited by-同舟云学术

A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors

Published:2007-05-01 Issue:9 Volume:13 Page:2692-2698
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Azzoli Christopher G.,Krug Lee M.,Gomez Jorge,Miller Vincent A.,Kris Mark G.,Ginsberg Michelle S.,Henry Roxanne,Jones Jessica,Tyson Leslie,Dunne Megan,Pizzo Barbara,Farmer Amy,Venkatraman Ennapadam,Steffen Robert,Sirotnak F.M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of l-leucovorin uptake and metabolism in the modulation of 5-fluorouracil efficacy and antifolate toxicity;Frontiers in Pharmacology;2024-08-21

2. Schedule-Dependent Synergy Between the Histone Deacetylase Inhibitor Belinostat and the Dihydrofolate Reductase Inhibitor Pralatrexate in T-and B-cell Lymphoma Cells in vitro;Frontiers in Cell and Developmental Biology;2020-10-09

3. Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates;Molecular Cancer Therapeutics;2019-10-01

4. Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology;Scientific Reports;2016-06-02

5. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance;Drug Resistance Updates;2015-11